GreenLight Biosciences (NASDAQ:GRNA) Shares Gap Up to $6.78

GreenLight Biosciences Holdings (NASDAQ:GRNAGet Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $6.78, but opened at $6.98. GreenLight Biosciences shares last traded at $6.89, with a volume of 387 shares trading hands.

The business has a fifty day moving average of $9.13.

A number of hedge funds and other institutional investors have recently bought and sold shares of GRNA. Penserra Capital Management LLC purchased a new position in GreenLight Biosciences in the 1st quarter worth approximately $25,000. Citigroup Inc. purchased a new position in GreenLight Biosciences in the 1st quarter worth approximately $55,000. Victory Capital Management Inc. purchased a new position in GreenLight Biosciences in the 1st quarter worth approximately $85,000. Sciencast Management LP purchased a new position in GreenLight Biosciences in the 1st quarter worth approximately $137,000. Finally, Bank of New York Mellon Corp purchased a new position in GreenLight Biosciences in the 1st quarter worth approximately $245,000. 40.69% of the stock is currently owned by institutional investors.

About GreenLight Biosciences (NASDAQ:GRNA)

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

See Also

Receive News & Ratings for GreenLight Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GreenLight Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.